Diagnostics & Research (BK2011) News Flow - Moomoo

Mobile

donwloadimg

Desktop

View more versions

English
中文繁體
中文简体

Markets
Products
News
Moo Community
- Feed
  
  Find inspiration for your next move
- Topics
  
  Discuss hot topics with like-minded traders
Learn
Investing
- Investment Choices
  
  Explore investment products
  Cash Sweep
  
  Stocks
  
  Fractional Shares
  
  ETFs
  
  Options
  
  Margin Trade
- Features
  
  See our powerful trading features in action
  Charts
  
  Stock Analysis
  
  Level 2 Data
  
  Nasdaq Market Depth
- Pricing
  
  Transparent fees, no account minimums

Log in

Open Account

Financial services in the moomoo app are provided by Moomoo Financial Inc. You will be redirected to Moomoo Financial Inc's web domain, where the account application pages are hosted.

Sign up/Log in

Log Out

English

Light

Dark

Back

Markets
Products
News
Moo Community
- Feed
  
  Find inspiration for your next move
Learn
Investing
- Investment Choices
  - Cash Sweep
  - Stocks
  - Fractional Shares
  - ETFs
  - Options
  - Margin Trade
- Features
- Pricing
  
  Transparent fees, no account minimums

English
中文繁體
中文简体

Dark
Light

Log in to access Online Inquiry

Back to the Top

Watchlist
Paper Trade
Screener
Heat Map
Institutional
Tracker

BK2011 Diagnostics & Research

Watchlist

4220.138
+56.152+1.35%

Close May 15 16:00 ET

4224.287High4165.917Low

4165.917Open4163.986Pre Close48.43MVolume41Rise59.15P/E (Static)4.32BTurnover3Flatline0.93%Turnover Ratio791.52BMarket Cap20Fall756.13BFloat Cap

Overview News Comments

News

Announcement

Ratings

Argus Raises Quest Diagnostics' Price Target to $163 From $155
MT Newswires13:48 ET
CareDx Analyst Ratings
BenzingaMay 15 11:31 ET
RadNet Analyst Ratings
BenzingaMay 15 09:55 ET
Radnet (RDNT) Gets a Buy From Truist Financial
TipRanksMay 15 07:26 ET
Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating
MT NewswiresMay 15 06:14 ET
Daiwa Securities Adjusts Price Target on Illumina to $120 From $133
MT NewswiresMay 15 05:58 ET
Buy Rating Affirmed for Guardant Health Amid Strong Q1 Performance and Positive Revenue Outlook
TipRanksMay 14 13:15 ET
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Dynavax (DVAX) and Natera (NTRA)
TipRanksMay 14 13:30 ET
Buy Rating Justified: CareDx's Strong Financial Performance and Market Potential
TipRanksMay 14 13:16 ET
VolitionRX Analyst Ratings
BenzingaMay 14 13:08 ET
IDEXX Laboratories Analyst Ratings
BenzingaMay 14 12:56 ET
Neuronetics Analyst Ratings
BenzingaMay 14 09:02 ET
Exagen Analyst Ratings
BenzingaMay 14 08:46 ET
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620
MT NewswiresMay 14 08:27 ET
Inotiv Analyst Ratings
BenzingaMay 14 08:16 ET
Natera Analyst Ratings
BenzingaMay 14 07:53 ET
Exagen's Strong Q1 Earnings and Growth Potential Justify Buy Rating
TipRanksMay 14 07:36 ET
TD Cowen Sticks to Its Hold Rating for Illumina (ILMN)
TipRanksMay 14 07:26 ET
Jefferies Downgrades Inotiv to Hold From Buy, Price Target Is $3.75
MT NewswiresMay 14 07:20 ET
Analysts' Top Healthcare Picks: Oculis Holding (OCS), Natera (NTRA)
TipRanksMay 14 07:01 ET

About moomoo

Terms & Conditions

Licensed Entities*

Your Privacy Choices

Careers / Contact:

hr@us.moomoo.com

The moomoo app is an online trading platform offered by Moomoo Technologies Inc. Securities, brokerage products and related services available through the moomoo app are offered by including but not limited to the following brokerage firms: Moomoo Financial Inc. regulated by the U.S. Securities and Exchange Commission (SEC), Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS), Futu Securities International (Hong Kong) Limited regulated by the Securities and Futures Commission of Hong Kong (SFC), Moomoo Financial Canada Inc. regulated by the Canadian Investment Regulatory Organization (CIRO) and Futu Securities (Australia) Ltd regulated by the Australian Securities and Investments Commission (ASIC).

For further information about Moomoo Financial Inc., please visit Financial Industry Regulatory Authority (FINRA)’s BrokerCheck. Brokerage accounts with Moomoo Financial Inc. are protected by the Securities Investor Protection Corporation (SIPC). Moomoo Financial Inc. is a member of Securities Investor Protection Corporation (SIPC), which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). It is important to understand that SIPC protects customer accounts against losses caused by the financial failure of the broker-dealer, but not against an increase or decrease in the market value of securities in customers' accounts. SIPC does not protect against market risk, which is the risk inherent in a fluctuating market. For further information about SIPC coverage for accounts with Moomoo Financial Inc., see www.sipc.org or request an explanatory brochure from Moomoo Financial Inc.

Options trading entails significant risk and is not appropriate for all customers. It is important that investors read Characteristics and Risks of Standardized Options before engaging in any options trading strategies. Options transactions are often complex and may involve the potential of losing the entire investment in a relatively short period of time. Certain complex options strategies carry additional risk, including the potential for losses that may exceed the original investment amount. Supporting documentation for any claims, if applicable, will be furnished upon request.

Investments in stocks, options, ETFs and other instruments are subject to risks, including possible loss of the amount invested. The value of investments may fluctuate and as a result, clients may lose the value of their investment. Past performance should not be viewed as an indicator of future results.

Margin trading involves interest charges and heightened risks, including the potential to lose more than invested funds or the need to deposit additional collateral. Before trading on margin, customers are advised to determine whether this type of trading is appropriate for them in light of their respective investment objective, experience, risk tolerance and financial situation.

Free trading refers to $0 commissions for Moomoo Financial Inc. self-directed individual cash or margin brokerage accounts of U.S. residents that trade U.S. listed securities via mobile devices or Web. Relevant SEC & FINRA fees may apply. For details, please see Commission and Fees.

All types of investments are risky and investors may suffer losses. Past performance of investment products does not guarantee future results. Electronic trading also poses risks to investors. The responsiveness of the trading system may vary due to market conditions, system performance, and other factors. Account access and trade execution may be affected by factors such as market volatility.

No content on the website shall be considered as a recommendation or solicitation for the purchase or sale of securities, futures, or other financial products. All information and data on the website are for reference only and no historical data shall be considered as the basis for predicting future trends.

Information contained on this website is general in nature and has been prepared without any consideration of customers’ investment objectives, financial situations or needs. Customers should consider the appropriateness of the information having regard to their personal circumstances before making any investment decisions.

Investment products are not insured by the Federal Deposit Insurance Corporation (FDIC) or guaranteed by a bank, and may decline in value.

The services and products offered on the website are subject to applicable laws and regulations, as well as relevant service terms and policies. The services and products are not available to all customers or in all geographic areas or in any jurisdiction where it is unlawful for us to offer such services and products.

Copyright © 2024 Moomoo Technologies Inc. All Rights Reserved.